摘要
目的对2例长岛型掌跖角化症(Nagashima-typePalmoplantarKeratosis,NPPK)患者的丝氨酸蛋白酶抑制剂B7(SERPINB7)基因全部外显子及外显子-内含子边界进行测序分析。方法采用聚合酶链式反应SERPINB7基因进行直接测序。结果1例患者检测到SERPINB7基因c.796C>T纯合突变,1例患者为c.796C>T与c.455G>T的复合杂合突变。结论SERPINB基因c.796C>T及c.455G>T突变可能为NPPK患者的致病突变位点。
Objective To investigate serine protease inhibitors B7(SERPINB7)gene mutation in two cases with Nagashima-type palmoplantar keratosis(NPPK).Methods All coding exons and exon-intron boundaries of SERPINB7 gene were amplified by PCR,and direct sequencing was performed.Results A homozygous mutation c.796C>T in SERPINB7 gene in one patient,and another patient habored a compound heterozygous c.796C>T combined with c.455G>T.Conclusion c.796C>T combined with c.455G >T mutations may be the pathogenetic mutation NPPK.
作者
赵娟
ZHAO Juan(Inner Monglia People's Hospital,Huhhot 010017 China)
出处
《内蒙古医学杂志》
2019年第7期784-785,764,共2页
Inner Mongolia Medical Journal
基金
内蒙古自治区人民医院青年基金项目(编号:2016095)